Active Awards Portfolio Dashboard
It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and clinical stage research. Check out our portfolio of active research awards in our interactive dashboard below. For a detailed list of CIRM-funded clinical trials, visit our Clinical Trials Dashboard.
Disease | Cell Type | Therapeutic or Technology | Institution | Stage | Project Objective | Details |
---|---|---|---|---|---|---|
Lung Disease, Fibrosis, Respiratory Disorders | Gene Therapy (All), Gene Therapy, cell free, Therapeutic Approach | Rejuvenation Technologies, Inc. | ![]() |
Pre-IND/IDE or Equivalent | ||
Diabetes, Metabolic Disorders | Donor cell therapy, Therapeutic Approach | Stanford | ![]() |
Pre-IND/IDE or Equivalent | ||
Infectious Disease | Biologic, Nucleic acid based therapy, Therapeutic Approach | VxBiosciences inc. | ![]() |
Pre-IND/IDE or Equivalent | ||
Neurological Disorders, Pediatrics | Gene Therapy (All), Gene Therapy, cell free, Therapeutic Approach | Mahzi Therapeutics | ![]() |
Pre-IND/IDE or Equivalent | ||
Breast Cancer, Cancer, Solid Tumors | Adult or Tissue Stem Cell | Gene Therapy (All), Gene-modified, donor cell therapy, Therapeutic Approach | COH | ![]() |
Pre-IND/IDE or Equivalent | |
Neurological Disorders, Other | Adult or Tissue Stem Cell | Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach | UCSD | ![]() |
Pre-IND/IDE or Equivalent | |
B cell cancers, Blood Cancer, Cancer | Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach | UC Davis | ![]() |
Pre-IND/IDE or Equivalent | ||
Cancer, Prostate Cancer, Solid Tumors | Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach | USC | ![]() |
Pre-IND/IDE or Equivalent | ||
Heart Disease, Hypertension, pulmonary arterial, Pulmonary Hypertension | Adult or Tissue Stem Cell | Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach | UCLA | ![]() |
Pre-IND/IDE or Equivalent | |
Neurological Disorders, Spinal Cord Injury | Adult or Tissue Stem Cell | Donor cell therapy, Therapeutic Approach | UC Irvine | ![]() |
Pre-IND/IDE or Equivalent | |
Duchenne Muscular Dystrophy, Skeletal/Smooth Muscle disorders | Somatic Cell | Gene Therapy (All), Gene Therapy, cell free, Therapeutic Approach | MyoGene Bio LLC | ![]() |
Pre-IND/IDE or Equivalent | |
B cell cancers, Blood Cancer, Cancer | Somatic Cell | Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach | UCSF | ![]() |
Pre-IND/IDE or Equivalent | |
Genetic Disorder, Metabolic Disorders | Somatic Cell | Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach | Immusoft Corporation | ![]() |
Pre-IND/IDE or Equivalent | |
Brain Cancer, Cancer, Solid Tumors | Somatic Cell | Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach | UCSF | ![]() |
Pre-IND/IDE or Equivalent | |
Heart Disease | iPS Cell | Biologic, Protein/peptide therapy, Therapeutic Approach | Regencor, Inc. | ![]() |
Pre-IND/IDE or Equivalent | |
Blood Disorders, IPEX Syndrome | Adult or Tissue Stem Cell | Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach | ImmunoVec | ![]() |
Pre-IND/IDE or Equivalent | |
Heart Disease | Adult or Tissue Stem Cell | Antibody, Biologic, Therapeutic Approach | UCLA | ![]() |
Pre-IND/IDE or Equivalent | |
Neurological Disorders, Stroke | iPS Cell | Donor cell therapy, Therapeutic Approach | UCLA | ![]() |
Pre-IND/IDE or Equivalent | |
Neurological Disorders, Stroke | iPS Cell | Donor cell therapy, Therapeutic Approach | PAVIR | ![]() |
Pre-IND/IDE or Equivalent | |
Blood Cancer, Cancer, Multiple Myeloma | Adult or Tissue Stem Cell | Gene Therapy (All), Gene-modified, donor cell therapy, Therapeutic Approach | UCLA | ![]() |
Pre-IND/IDE or Equivalent | |
Cancer, Melanoma, Solid Tumors | Adult or Tissue Stem Cell | Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach | UCLA | ![]() |
Pre-IND/IDE or Equivalent | |
Brain Injury, hypoxic, ischemic, Neurological Disorders, Pediatrics | Adult or Tissue Stem Cell | Donor cell therapy, Therapeutic Approach | Sanford-Burnham | ![]() |
Pre-IND/IDE or Equivalent | |
Blood Cancer, Cancer, Multiple Myeloma | Adult or Tissue Stem Cell | Personalized cell therapy, Therapeutic Approach | UCLA | ![]() |
Pre-IND/IDE or Equivalent | |
Neurological Disorders, Spinal Cord Injury | Embryonic Stem Cell | Donor cell therapy, Other Components, Therapeutic Approach | UCSD | ![]() |
Pre-IND/IDE or Equivalent | |
Neurological Disorders, Traumatic Brain Injury | Embryonic Stem Cell | Donor cell therapy, Therapeutic Approach | UC Irvine | ![]() |
Pre-IND/IDE or Equivalent | |
Blood Disorders, Hyper IgM Syndrome, Immune Disease | Adult or Tissue Stem Cell | Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach | UCLA | ![]() |
Pre-IND/IDE or Equivalent | |
Age-related macular degeneration, Vision Loss | Adult or Tissue Stem Cell | Donor cell therapy, Therapeutic Approach | Stanford | ![]() |
Pre-IND/IDE or Equivalent | |
Bladder or Urinary Tract Disorder, Incontinence, Skeletal/Smooth Muscle disorders | iPS Cell | Personalized cell therapy, Therapeutic Approach | Stanford | ![]() |
Pre-IND/IDE or Equivalent | |
Epidermolysis Bullosa, Skin Disease | iPS Cell | Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach | Stanford | ![]() |
Pre-IND/IDE or Equivalent | |
Intestinal Disease, Metabolic Disorders, Neurological Disorders, Pediatrics | iPS Cell | Donor cell therapy, Therapeutic Approach | CHLA | ![]() |
Pre-IND/IDE or Equivalent | |
UC Davis | ||||||
Brain Cancer, Cancer, Solid Tumors | Adult or Tissue Stem Cell | Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach | Stanford | ![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Age-related macular degeneration, Vision Loss | Embryonic Stem Cell | Donor cell therapy, Therapeutic Approach | Regenerative Patch Technologies LLC | ![]() |
Clinical Trial, Phase 2 | |
Blood Cancer, Cancer, Leukemia, Acute Myeloid (AML) | Gene Therapy (All), Gene-modified, donor cell therapy, Therapeutic Approach | COH | ![]() |
Clinical Trial, Phase 1 or Phase 1/2 | ||
HIV/AIDS, Infectious Disease | Other | COH | ![]() |
Clinical Trial, Phase 1 or Phase 1/2 | ||
Corneal Damage, Vision Loss | Adult or Tissue Stem Cell | Biologic, Exosomes based therapy, Therapeutic Approach | Combangio | ![]() |
Clinical Trial, Phase 2 | |
Bone or Cartilage Disease, Hearing Loss, Intellectual Disability, Metabolic Disorders, Neurological Disorders, Vision Loss | Somatic Cell | Personalized cell therapy, Therapeutic Approach | Immusoft Corporation | ![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Cancer, Solid Tumors | Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach | Eureka Therapeutics, Inc. | ![]() |
Clinical Trial, Phase 1 or Phase 1/2 | ||
Anemia, Blood Disorders | Adult or Tissue Stem Cell | Antibody, Biologic, Therapeutic Approach | Stanford | ![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
B cell cancers, Blood Cancer, Cancer | Somatic Cell | Gene Therapy (All), Gene-modified, donor cell therapy, Therapeutic Approach | Angiocrine | ![]() |
Clinical Trial, Phase 3 | |
Bone or Cartilage Disease, Osteoarthritis | Somatic Cell | Gene Therapy (All), Gene Therapy, cell free, Therapeutic Approach | Genascence Corporation | ![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Cancer, Colon Cancer, Solid Tumors | Tachyon Therapeutics, Inc | ![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |||
Anemia, Blood Disorders | Somatic Cell | Cell processing & handling, Immune tolerance/management, Technology | COH | ![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Anemia, Blood Disorders, Bone Marrow Transplant and Viral Infection | Adult or Tissue Stem Cell | Immune tolerance/management, Technology | Stanford | ![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Epilepsy, Neurological Disorders | Embryonic Stem Cell | Donor cell therapy, Therapeutic Approach | Neurona Therapeutics | ![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
HIV/AIDS, Infectious Disease | Gene Therapy (All), Gene Therapy, cell free, Therapeutic Approach | Excision BioTherapeutics | ![]() |
Clinical Trial, Phase 1 or Phase 1/2 | ||
Bladder or Urinary Tract Disorder, Skeletal/Smooth Muscle disorders | Somatic Cell | Technology, Tissue engineering | Wake Forest University Health Sciences | ![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Brain Cancer, Cancer, Solid Tumors | Adult or Tissue Stem Cell | Gene Therapy (All), Gene-modified, donor cell therapy, Therapeutic Approach | COH | ![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Blood Disorders, IPEX Syndrome | Adult or Tissue Stem Cell | Gene Therapy (All), Gene-modified, personalized cell therapy, Therapeutic Approach | Stanford | ![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Muscle Injury, Skeletal/Smooth Muscle disorders | Adult or Tissue Stem Cell | Personalized cell therapy, Therapeutic Approach | UC Davis | ![]() |
Clinical Trial, Phase 1 or Phase 1/2 |